The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia

I. Kondova Topuzovska, S. Petrusevska Marinkovic, G. Kondov, S. Alabakovska, A. Anastasovska (Skopje, Fyrom)

Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Session: Management of pneumonia due to hospital pathogens
Session type: Thematic Poster Session
Number: 2553
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Kondova Topuzovska, S. Petrusevska Marinkovic, G. Kondov, S. Alabakovska, A. Anastasovska (Skopje, Fyrom). The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia. Eur Respir J 2012; 40: Suppl. 56, 2553

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011

I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009


Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007

I like invasive techniques to define their role in the diagnosis of pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009


Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Factors associated with unknown aetiology in patients with community-acquired pneumonia
Source: Eur Respir J 2002; 20: 1254-1262
Year: 2002



An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007


Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011


Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 991-992
Year: 2011


Clinical decision support system for diagnosing patients with community-acquired pneumonia
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011


Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia.
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


The role of endothelin-1 in hospitalized patients with community-acquired pneumonia.
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019


Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer
Source: Eur Respir Rev 2008; 17: 83-85
Year: 2008



Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011


Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012

Etiology and clinical outcome of community-acquired pneumonias in hospitalized children
Source: Eur Respir J 2007; 30: Suppl. 51, 398s
Year: 2007

Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008